Jan W. Gratama

Best Publications

• Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience

  Cor H.J. Lamers;Stefan Sleijfer;Arnold G. Vulto;Wim H.J. Kruit

  1100
  Citations

• Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

  Cor H. J. Lamers;Stefan Sleijfer;Sabine van Steenbergen;Pascal van Elzakker

  786
  Citations

• Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

  Andy C Rawstron;Alberto Orfao;Meral Beksac;Ludmila Bezdickova

  653
  Citations

• Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells

  Anieta M. Sieuwerts;Jaco Kraan;Joan Bolt;Petra van der Spoel

  586
  Citations

• High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

  Monique Terwijn;Wim L J van Putten;Angèle Kelder;Vincent H J van der Velden

  512
  Citations

• Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT

  Joost W. J. van Esser;Bronno van der Holt;Ellen Meijer;Hubert G. M. Niesters

  510
  Citations

• Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.

  A. E. C. Broers;R. van der Holt;J. W. J. van Esser;J. W. Gratama

  488
  Citations

• Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.

  Joost W. J. van Esser;Hubert G. M. Niesters;Bronno van der Holt;Ellen Meijer

  458
  Citations

• Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

  Jan W. Gratama;Joost W. J. van Esser;Cor H. J. Lamers;Claire Tournay

  423
  Citations

• Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells

  Cor H. J. Lamers;Ralph Willemsen;Pascal van Elzakker;Sabine van Steenbergen-Langeveld

  407
  Citations

• Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.

  Bianca Mostert;Stefan Sleijfer;John A. Foekens;Jan Willem Gratama

  390
  Citations

• Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals

  Florian Kern;Torsten Bunde;Nicole Faulhaber;Nicole Faulhaber;Felix Kiecker

  347
  Citations

• Considerations for the control of background fluorescence in clinical flow cytometry

  Ruud Hulspas;Maurice R.G. O'Gorman;Brent L. Wood;Jan W. Gratama

  303
  Citations

• Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells.

  J W Gratama;A Orfao;D Barnett;B Brando

  279
  Citations

• Cytofluorometric methods for assessing absolute numbers of cell subsets in blood

  Bruno Brando;David Barnett;George Janossy;Francis Mandy

  276
  Citations

• Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody.

  Silvana Canevari;Gerrit Stoter;Flavio Arienti;Giorgio Bolis

  273
  Citations

• Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR

  Anieta M. Sieuwerts;Jaco Kraan;Joan Bolt-de Vries;Petra van der Spoel

  242
  Citations

• mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients

  Anieta M. Sieuwerts;Bianca Mostert;Joan Bolt-de Vries;Dieter Peeters

  236
  Citations

• Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR

  R A Willemsen;M E M Weijtens;C Ronteltap;Z Eshhar

  232
  Citations

• Standardizing flow cytometry: construction of a standardized fluorescence calibration plot using matching spectral calibrators

  A. Schwartz;E. Fernández Repollet;R. Vogt;Jan W. Gratama

  197
  Citations